Certara (CERT) Stock Forecast & Price Target

Compare

266 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CERT Analyst Ratings

Moderate Buy

5 Buy

6 Hold

0 Sell

Based on 11 analysts giving stock ratings to

Certara

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CERT Stock 12 Month Forecast

Average Price Target

$10.00

▲(41.64% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Certara in the last 3 months. The average price target is $10.00 with a high forecast of $13.00 and a low forecast of $7.00. The average price target represents a 41.64% change from the last price of $7.06.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","8":"$8","10":"$10","12":"$12","14":"$14"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$13.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$10.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,8,10,12,14],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.05,7.507692307692308,7.9653846153846155,8.423076923076923,8.88076923076923,9.338461538461539,9.796153846153846,10.253846153846155,10.711538461538462,11.169230769230769,11.626923076923077,12.084615384615386,12.542307692307691,{"y":13,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.05,7.276923076923077,7.503846153846154,7.730769230769231,7.957692307692308,8.184615384615384,8.411538461538461,8.638461538461538,8.865384615384615,9.092307692307692,9.319230769230769,9.546153846153846,9.773076923076923,{"y":10,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.05,7.046153846153846,7.042307692307692,7.038461538461538,7.0346153846153845,7.030769230769231,7.026923076923077,7.023076923076923,7.019230769230769,7.015384615384615,7.0115384615384615,7.007692307692308,7.003846153846154,{"y":7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":11.98,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.87,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.29,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.52,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.54,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.66,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.37,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.63,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.85,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.81,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.3,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.05,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$13.00

Average Price Target$10.00

Lowest Price Target$7.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Dan Leonard

UBS

$10

Buy

41.64%

Upside

Reiterated

03/06/26

Certara: Capitalizing on Growing Biosimulation Adoption Despite Near-Term Software Headwinds

Luke Sergott

Barclays

Hold

13.31%

Upside

Downgraded

03/06/26

Certara downgraded to Equal Weight from Overweight at BarclaysCertara downgraded to Equal Weight from Overweight at Barclays

Joseph Vruwink

Robert W. Baird

$11→$8

Hold

13.31%

Upside

Reiterated

02/27/26

Certara price target lowered to $8 from $11 at BairdCertara price target lowered to $8 from $11 at Baird

Sean Dodge

BMO Capital

$9→$7

Hold

-0.85%

Downside

Reiterated

02/27/26

BMO Capital Keeps Their Hold Rating on Certara (CERT)

Matt Hewitt

Craig-Hallum

$16→$10

Hold

41.64%

Upside

Downgraded

02/27/26

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Indivior (INDV)

Scott Schoenhaus

KeyBanc

$12→$10

Buy

41.64%

Upside

Reiterated

02/27/26

Certara price target lowered to $10 from $12 at KeyBancCertara price target lowered to $10 from $12 at KeyBanc

Brendan Smith

TD Cowen

$10

Buy

41.64%

Upside

Reiterated

02/26/26

Analysts' Top Healthcare Picks: Phathom Pharmaceuticals (PHAT), Certara (CERT)

Max Smock

William Blair

―

Hold

―

Reiterated

02/26/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Certara (NASDAQ: CERT), Soligenix (NASDAQ: SNGX) and Day One Biopharmaceuticals (NASDAQ: DAWN)

Michael Cherny

Leerink Partners

$13

Buy

84.14%

Upside

Upgraded

01/06/26

Certara upgraded to Outperform from Market Perform at LeerinkCertara upgraded to Outperform from Market Perform at Leerink

Craig Hettenbach

Morgan Stanley

$16→$12

Hold

69.97%

Upside

Reiterated

12/18/25

Certara price target lowered to $12 from $16 at Morgan StanleyCertara price target lowered to $12 from $16 at Morgan Stanley

Jeffrey Garro

Stephens

$12

Buy

69.97%

Upside

Assigned

12/12/25

Certara price target lowered to $12 from $15 at StephensCertara price target lowered to $12 from $15 at Stephens

Jamie Clark

Rothschild & Co Redburn

$10

Buy

41.64%

Upside

Initiated

11/21/25

Certara initiated with a Buy at Rothschild & Co RedburnCertara initiated with a Buy at Rothschild & Co Redburn

Constantine Davides

Citizens JMP

―

Hold

―

Reiterated

05/06/25

Citizens JMP Sticks to Their Hold Rating for Certara (CERT)

David Windley

Jefferies

$12.5→$14.5

Hold

105.38%

Upside

Reiterated

04/21/25

Certara Inc. (CERT) PT Raised to $14.50 at JefferiesJefferies analyst David Windley raised the price target on Certara Inc. (NASDAQ: CERT) to $14.50 (from $12.50) while maintaining a Hold rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Dan Leonard

UBS

$10

Buy

41.64%

Upside

Reiterated

03/06/26

Certara: Capitalizing on Growing Biosimulation Adoption Despite Near-Term Software Headwinds

Luke Sergott

Barclays

Hold

13.31%

Upside

Downgraded

03/06/26

Certara downgraded to Equal Weight from Overweight at BarclaysCertara downgraded to Equal Weight from Overweight at Barclays

Joseph Vruwink

Robert W. Baird

$11→$8

Hold

13.31%

Upside

Reiterated

02/27/26

Certara price target lowered to $8 from $11 at BairdCertara price target lowered to $8 from $11 at Baird

Sean Dodge

BMO Capital

$9→$7

Hold

-0.85%

Downside

Reiterated

02/27/26

BMO Capital Keeps Their Hold Rating on Certara (CERT)

Matt Hewitt

Craig-Hallum

$16→$10

Hold

41.64%

Upside

Downgraded

02/27/26

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Indivior (INDV)

Scott Schoenhaus

KeyBanc

$12→$10

Buy

41.64%

Upside

Reiterated

02/27/26

Certara price target lowered to $10 from $12 at KeyBancCertara price target lowered to $10 from $12 at KeyBanc

Brendan Smith

TD Cowen

$10

Buy

41.64%

Upside

Reiterated

02/26/26

Analysts' Top Healthcare Picks: Phathom Pharmaceuticals (PHAT), Certara (CERT)

Max Smock

William Blair

―

Hold

―

Reiterated

02/26/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Certara (NASDAQ: CERT), Soligenix (NASDAQ: SNGX) and Day One Biopharmaceuticals (NASDAQ: DAWN)

Michael Cherny

Leerink Partners

$13

Buy

84.14%

Upside

Upgraded

01/06/26

Certara upgraded to Outperform from Market Perform at LeerinkCertara upgraded to Outperform from Market Perform at Leerink

Craig Hettenbach

Morgan Stanley

$16→$12

Hold

69.97%

Upside

Reiterated

12/18/25

Certara price target lowered to $12 from $16 at Morgan StanleyCertara price target lowered to $12 from $16 at Morgan Stanley

Jeffrey Garro

Stephens

$12

Buy

69.97%

Upside

Assigned

12/12/25

Certara price target lowered to $12 from $15 at StephensCertara price target lowered to $12 from $15 at Stephens

Jamie Clark

Rothschild & Co Redburn

$10

Buy

41.64%

Upside

Initiated

11/21/25

Certara initiated with a Buy at Rothschild & Co RedburnCertara initiated with a Buy at Rothschild & Co Redburn

Constantine Davides

Citizens JMP

―

Hold

―

Reiterated

05/06/25

Citizens JMP Sticks to Their Hold Rating for Certara (CERT)

David Windley

Jefferies

$12.5→$14.5

Hold

105.38%

Upside

Reiterated

04/21/25

Certara Inc. (CERT) PT Raised to $14.50 at JefferiesJefferies analyst David Windley raised the price target on Certara Inc. (NASDAQ: CERT) to $14.50 (from $12.50) while maintaining a Hold rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Certara

3 Months

xxx

Success Rate

4/5 ratings generated profit

Average Return

+2.10%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +2.10% per trade.

1 Year

Dan LeonardUBS

Success Rate

1/5 ratings generated profit

Average Return

-11.02%

a rating ―

Copying Dan Leonard's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -11.02% per trade.

2 Years

xxx

Success Rate

1/5 ratings generated profit

Average Return

-17.24%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -17.24% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CERT Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CERT has received 9 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. CERT average Analyst price target in the past 3 months is 10.00.

Each month's total comprises the sum of three months' worth of ratings.

CERT Financial Forecast

CERT Earnings Forecast

Next quarter’s earnings estimate for CERT is $0.11 with a range of $0.09 to $0.12. The previous quarter’s EPS was $0.09. CERT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CERT has Performed in-line its overall industry.

CERT Sales Forecast

Next quarter’s sales forecast for CERT is $106.13M with a range of $104.10M to $107.47M. The previous quarter’s sales results were $103.65M. CERT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CERT has Performed in-line its overall industry.

CERT Stock Forecast FAQ

What is CERT’s average 12-month price target, according to analysts?

Based on analyst ratings, Certara’s 12-month average price target is 10.00.

What is CERT’s upside potential, based on the analysts’ average price target?

Certara has 41.64% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CERT a Buy, Sell or Hold?

Certara has a consensus rating of Moderate Buy which is based on 5 buy ratings, 6 hold ratings and 0 sell ratings.

What is Certara’s price target?

The average price target for Certara is 10.00. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $13.00 ,the lowest forecast is $7.00. The average price target represents 41.64% Increase from the current price of $7.06.

What do analysts say about Certara?

Certara’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of CERT?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Certara (CERT) Stock Forecast & Price Target

CERT Analyst Ratings

CERT Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Certara

CERT Analyst Recommendation Trends

CERT Financial Forecast

CERT Earnings Forecast

CERT Sales Forecast

CERT Stock Forecast FAQ

Detailed List of Analyst Forecasts